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Sprocedure, including myocardial infarction (MI), cardiac death, and target vessel
revascularization (TVR).
Results: The NERS score II system consisted of 16 (7 clinical and 9 angiographic)
variables. An NERS score II 19 demonstrated enhanced MACE sensitivity and
speciﬁcity of 84.0% and 76.0% (MACE as the state variable), respectively, which
were similar to the NERS score but signiﬁcantly higher compared to the SYNTAX
score. An NERS II score 19 was the only independent predictor of cumulative
MACEs (hazard ratio: 3.27; 95% CI: 1.86 to 5.23; p0.001) and stent thrombosis
(odds ratio: 22.15; 95% CI: 12.47 to 57.92; p0.001) at follow-up
Conclusions: The NERS score II, similar to the conventional NERS score, is more
predictive of MACEs than the SYNTAX score in UPLMCA patients after implan-
tation of a DES.
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Background: Percutaneous coronary intervention (PCI) of complex true coronary
bifurcation lesions is challenging and whether to stent side branch dedicatedly is still
debatable. To date there is no published study showing the safety and efﬁcacy of the
Everolimus-eluting stent (EES) in true bifurcation lesions with major side branch (SB)
involvement treated with dedicated 2 stents (2S). We sought to compare outcomes of
a dedicated 2S with a provisional 1S strategy in these unique patients.
Methods: We identiﬁed 203 patients with complex true bifurcation lesions
(Medina: 1,1,1; 1,0,1; and 0,1,1) with a minimum SB diameter of >2.3mm (assessed
by quantitative coronary angiography) who underwent bifurcation PCI using EES
from February 2010 to December 2011. The PCI strategies included provisional 1S
(n¼96) and dedicated 2S (n¼107) technique. Survival curves were constructed for
time-to-event variables with Kaplan-Meier methodology and compared by log-rank
test.
Results: The baseline characteristics were well matched between two PCI strategies.
In hospital major adverse cardiac event (MACE) and post procedure MI (CK-
MB>3xNormal) (10.42% provisional stent vs. 7.48% 2-Stent implantation, P¼0.46).
At 1-year follow-up, MACE rates were similar for both (2S vs. 1S) techniques. Time
to MACE event analysis is depicted with log rank test (P¼0.31).
Conclusions: With EES use, a dedicated 2S technique appears to be a safe and
effective PCI strategy in patients with complex true bifurcation lesion with large side
branch vessel involvement.JACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT AbstrTCT-401
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Background: The present study aimed to compare the immediate success and long-
term follow up between the femoral (TF)and transradial (TR) approach for stenting of
unprotected distal left main (LM) bifurcation lesions.
Methods: 412 consecutive patients with distal LM bifurcation lesions underwent stent
implantation (226 in the transradial group and 186 in femoral group) were enrolled.
The primary endpoint was major adverse cardiac events (MACE), a composite of
cardiac death, myocardial infarction, and target vessel revascularization. In hospital
mortality and bleeding, follow up MACE were compared according to vascular access
method.
Results: Clinical and angiographic characteristics (Syntax score) were similar
between groups. 6Fr catheter were more commonly used in TR(100%, TF 15%). 2
stents technique were less commonly used in TR (32% vs 51% P < 0.01). All patients
were implanted with drug eluting stents. For TR patients, bifurcation stent technique
included Culotte (40%), modiﬁed crush (35%), T stent (25%), For TF patients
,bifurcation strategies were crush (60%), T stenting (17%), Culotte (17%) and
kissing or V stenting (6%). Use of intravascular ultrasound were also similar
between two access(40 % versus 36% p¼ 0.42) . No cross over between 2 groups.
No signiﬁcant differences were observed between TR and TF methods for procedural
success (92% TR vs. 96% TR, p ¼ 0.24) or total procedural time. However, duration
of hospital stay and in-hospital occurrence of major or minor bleeding (1.6% vs.
3.5%, p <0.01) were signiﬁcantly lower with TR access. In hospital mortality rate is
similar (TR 0.8% vs. TF 2.1% p¼0.28). Over a median follow-up period of 36
months, rates of MACE did not statistically differ among TR and TF groups (10.6%,
vs. 11.8% p¼ 0.69), respectively. Cox regression showed that two stent (OR 1.21
95%CI 1.05 – 5.12 p < 0.01) but not access route were negative predicative factor
for MACE.
Conclusions: TR access for LM bifurcation stenting is not inferior to TF in term of
efﬁcacy and long term follow-up but associated with decreased rate of bleeding.
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Background: An acute side branch occlusion after stent implantation due to unsuc-
cessful wire-crossing of the side branch could induce myocardial damage and
contribute to poor long term outcomes. However, the necessary wiring to cross
extremely angulated bifurcation is distressed.
Methods: The aim of this study was to evaluate the safety and feasibility of
a “Reversed Wire Technique [RWT]” for treating bifurcation lesions in PCI. This
technique requires hydrophilic-coated wire with a hairpin bend curve at the tip and
a double lumen microcatheter.
Results: Of 3,847 consecutive lesions treated with PCI from Aug 2009 to May 2013,
RWT was used in 21 cases including 7 CTO cases. Of 18 bifurcation lesions treated
with RWT, 18 cases had previous failed attempts of wiring to the side branch via
regular methods (The mean number of used wire before RWT was 1.70.9). The
bifurcation lesions treated with RWT were most frequently located in the left anterior
descending artery (57%) followed by the left circumﬂex artery (24%), and the right
coronary artery (19%). The mean angle between the main-vessel and the side-branch
was 13121 degrees. Successful wire crossing was achieved in 81% of cases. All
cases using RWT underwent kissing-balloon inﬂation after wire-crossing. The
patency of the side-branch immediately after the procedure was 100%, if RWT was
successful.
Conclusions: The RWT is a useful method for the salvage of extremely angulated
bifurcation lesions and for eliminating wasted wire, although this technique required
several “Tips and Tricks”. This technique also can be applied to CTO procedure.acts/POSTER/Bifurcation and Left Main Interventions B125
Table. 1-year outcomes according to bifurcation treatment
Bifurcation
(n=1,317)
No bifurcation
(n=7,266) p value
MACE (Cardiac death, MI or TLR) 8.79% 6.48% 0.002
Cardiac death 0.79% 1.10% 0.31
MI (any) 4.02% 3.05% 0.067
Peri-procedural MI 2.28% 1.27% 0.004
TVR (any) 8.58% 6.41% 0.004
Deﬁnite/probable ST 0.70% 0.86% 0.56
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Background: ADAPT-DES was a prospective, multicenter, real-world registry of
8,583 consecutive pts at 11 international centers undergoing percutaneous coronary
intervention (PCI) with DES designed to determine the frequency, timing, and
correlates of early and late stent thrombosis (ST). Treatment of bifurcation lesions has
been shown to be associated with an increased risk of ST and worse clinical outcome.
We therefore analyzed the impact of bifurcation PCI on outcomes at 1 year.
Methods: Univariable and a fully adjusted multivariable analysis including propensity
score stratiﬁcation were performed to determine the relationship between bifurcation
PCI and subsequent events.
Results: During the index procedure, bifurcation lesions were treated in 1,317
(15.7%) of 8,583 pts. Pts in the bifurcation group were less likely to be female (22.2%
vs. 26.6%, p<0.001), diabetic (28.2% vs. 33.2%, p<0.001), or have ACS (47.2% vs.
52.5%, p<0.001). Post-procedure platelet reactivity was lower among patients
undergoing bifurcation PCI (mean P2Y12 PRU 183 vs. 189, p¼0.017). Pts with
bifurcation PCI had more total stents (2.10 vs. 1.65, p<0.0001) resulting in longer
total stent length (39.2 vs. 31.2 mm, p<0.0001). Bifurcation lesions were more often
in LAD territory (48.9% vs. 37.0%, p<0.0001). Both branches were stented in 19.1%
of all bifurcation lesions, and ﬁnal kissing was done in 46.1%. The 1 year unadjusted
rates of adverse outcomes are shown in the Table. In propensity adjusted models,
bifurcation treatment was not independently associated with 1-year MACE (HR [95%
CI] ¼ 1.13 [0.89, 1.42, p¼0.32), cardiac death (0.75 [0.31, 1.54], p¼0.43), ST (0.64
[0.30, 1.36], p¼0.24), or TVR (1.13 [0.89, 1.43], p¼0.31).
Conclusions: These data, drawn from a large prospective registry of contemporary
DES use, show that bifurcation lesion treatment is frequent, and is not necessarily
associated with a worse prognosis at 1 year.B126 JACC Vol 62/18/Suppl B j October 27–November 1, 2TCT-404
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Background: POLBOS is the randomized, prospective, multicentre study planned to
compare two intervention strategies for bifurcation treatment: provisional T-stenting
(PTS) with any regular drug-eluting stent (DES) and dedicated bifurcation paclitaxel-
eluting stent BiOSS Expert (Balton, Poland).
Methods: Between September 2010 and December 2012 in four centers in Poland
patients with stable CAD or NSTE-ACS were randomized to the group where BiOSS
Expert was implanted or to the group where regular DES was used. An angiographic
control was planned at 12 months in all patients. The primary end-point of the study is
the rate of death, MI, ST and TLR after 12 months. At the time of TCT 2013 complete
clinical 9-month follow-up will be available as well as 90% of angiographic controls
after 12 months.
Results: BiOSS Expert was implanted in 119 patients (49.4%) and regular DES was
implanted in 122 patients (50.6%). The average age of patients did not differ signif-
icantly between groups (BiOSS vs DES: 66.5 vs 66.8 yrs). In BiOSS group there were
signiﬁcantly more patients with NSTE-ACS (9.6% vs 3.5%), diabetes (32.2% vs
16.8%), prior MI and prior CABG. In DES group there were more patients addicted to
smoking (13% vs 22.1%). The dominant vessel was LAD (BiOSS vs DES: 52.1% vs
70.5%) followed by LMS (22.7% vs 13.9%, respectively). In DES group 35.4% of
stents eluted paclitaxel (PES). There were following nominal stent parameters in
BiOSS group: 3.690.36mm x 2.990.36mm x 16.961.44mm and in DES group:
3.270.49mm x 20.66.96 mm. Except for 2 (1.64%) cases in DES group and 1
(0.84%) in BiOSS group all stents were implanted successfully. There were 16%
(BiOSS) and 11.2% (DES) cases with second stent implanted within the side branch.
At six months all patients were uneventful. Up to now control angiography was
performed in 76% of patients in BiOSS group and in 74% in DES group. TLR was,
respectively, 10.99% vs 8.9% (p ¼ 0.5). Nevertheless, within DES group TLR in PES
subgroup was 12.8% and in –olimus subgroup – 5.7%
Conclusions: 9-month follow-up showed that BiOSS Expert provides satisfactory
results which seem to be inferior to those obtained by means of –limus eluting stents,
but comparable with those of PES.
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Background: The provisional T-stenting (PTS) is the recommended strategy for the
coronary bifurcation treatment. However, results obtained with use of regular drug
eluting stents (DES) are not optimal and relatively often associated with a side branch
compromise and restenosis. Dedicated bifurcation stents are claimed to be a solution
for these complications. POLBOS II study is the continuation of POLBOS study,
which paclitaxel-eluting stent BiOSS Expert was assessed in.
Methods: It is a randomized multicenter study planned to compare two strategies for
the bifurcation treatment – PTS with any regular DES or with a dedicated bifurcation
sirolimus-eluting stent BiOSS LIM (Balton, Poland) in patients with CAD or NSTE-
ACS. An angiographic control was planned at 12 months in all patients. The primary
end-point of the study is the rate of death, MI, ST and TLR after 12 months. The aim
is to enroll 120 patients (60 in each group).
Results: The enrollment started in November 2012. To date, 75 patients (64% males)
were randomized (40 inBiOSS group, 35 inDES group). The average agewas 649 yrs.
The dominant vessel was LAD (50%) followed by LMS (33%). 72% of cases were true
bifurcations. All stents were implanted successfully. There were 12.5 and 14.3% of013 j TCT Abstracts/POSTER/Bifurcation and Left Main Interventions
